Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Doctors and the DEA Free full text
Top Ten Searches
parkinson's neuritis neuralgia myasthenia gravis lactic acidosis ataxia seizure tinnitus migraine hypotoniaYour Article Summary
Anti-CTLA-4 antibody therapy associated autoimmune hypophysitis: serious immune related adverse events across a spectrum of cancer subtypes
Pituitary, 07/30/09
Fleseriu M et al. – The cases highlight the importance of early screening and treatment for hypopituitarism in all subjects undergoing treatment with anti–CTLA–4 therapy to prevent a potentially fatal outcome from secondary adrenal insufficiency, a readily treatable disease.
Related Articles
Phase I Study of Ipilimumab, an Anti–CTLA-4 Monoclonal Antibody, in Patients with Relapsed and Refractory B-Cell Non–Hodgkin Lymphoma
Clinical Cancer Research, 10/12/09
Relevance Score: 78%
Influence of interferon-beta therapy switching on neutralising antibody titres: results from the Austrian Switch Study (ASS)
Multiple Sclerosis, 11/18/09
Relevance Score: 69%
Learning the lessons of antitumour necrosis factor therapy-associated psoriasis
Canadian Journal of Gastroenterology, 10/13/09
Relevance Score: 68%
Prognostic value of regulatory T cells, lymphoma-associated macrophages, and MUM-1 expression in follicular lymphoma treated before and after the introduction of monoclonal antibody therapy: A Southwest Oncology Group Study
Annals of Oncology, 11/09/09
Relevance Score: 67%
Lymphoma in patients treated with anti-TNF. Results of the 3-year prospective French RATIO registry.
Annals of Rheumatic Diseases, 10/22/09
Relevance Score: 67%
Today in Neuroendocrinology...keeping you current
Receive free subspecialty "5-minute updates" via email
Evaluation of antioxidant systems in pituitary-adrenal axis diseases
Pituitary, 12/18/09
A heritable predisposition to pituitary tumors
Pituitary, 12/18/09
The risk for breast cancer is not evidently increased in women with hyperprolactinemia
Pituitary, 12/18/09
Sponsor
Article Search
Sponsor
Sponsor


See Latest Articles


